To be fair, by comparison to the other drugs, they are moving forward at an agreeable pace when directly compared to peers … obviously I’d love to see the share price back up too … “The United States has arguably the most stringent regulations regarding approval of medical drugs and devices in the world. The average time from FDA application to approval of drugs is 12 years, and the estimated average cost of taking a new drug from concept to market exceeds $1 billion.”
However, after noting the above …. With covid a current global issue - covid specific drugs and therapeutics they have sped up the process … that’s why qnta shifted gears to put escozine through as a covid therapeutic in order to get the ingredient escozine approved to then subsequently once that’s secured put forward as an orphan cancer drug ..
You and others think they can simply run out and “get license agreements” as if you are sending them out to get a pizza … I think maybe to many think the real world likes an episode of shark tank …
They showed the efficacy testing and data and then discussed in CC and PR pushes that they need to also present data on each isolated ingredient used in the drugs etc etc …
It’s Christmas Eve, I wish everyone and their loved ones family and friends who celebrate a very merry Christmas!!! To those who do not celebrate I send wishes of a very happy healthy and prosperous New Years!! May 2022 be very GREEN on the otc ;)
